The main changes in the recommended guidelines for the management of Barrett’s oesophagus by the British Society of Gastroenterology are highlighted, together with their value in the context of the numerous other guidelines and manuscripts that are already available. The working party of the BSG has recently produced a document updating recommended guidelines for the management of Barrett’s oesophagus (BO). In this article, the main changes in recommendations are highlighted and their value in the context of the numerous other guidelines and manuscripts that are already available are discussed. BO is defined as an endoscopically apparent area above the oesophagogastric junction that is suggestive of Barrett’s which is supported by the finding of columnar lined oesophagus on histology. The presence of areas of intestinal metaplasia (IM), although often present, is not a requirement for diagnosis. For patients with BO but without dysplasia, the recommended surveillance protocols are two yearly, four quadrant biopsies every 2 cm, but jumbo biopsies are not required.

Research & Reports in Gastroenterology is using online manuscript submission, review and tracking systems of SciTechnol for quality and quick review processing. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process. Publishers can see what manuscripts are in the pipeline awaiting publication. Email is sent automatically to appropriate parties when significant events occur.

Submit manuscripts at https://www.scholarscentral.org/submissions/research-reports-gastroenterology.html or an e-mail attachment to the Editorial Office at manuscripts@scitechnol.com

Best Regards,
Editorial Manager
Research and Reports in Gastroentrology
Email: gastro@clinicalmedicaljournals.com